Idexx Laboratories | IDXX - Current Liabilities


Idexx Laboratories reported $1.3B in Current Liabilities for its fiscal quarter ending in March of 2026.





Current Liabilities Change Date
Abbott USD 18.38B 1.88B Mar/2026
Accuray USD 199.44M 4.83M Dec/2025
Align Technology USD 1.91B 14.16M Mar/2026
AngioDynamics USD 71.96M 3.68M Sep/2025
Dentsply International USD 1.21B 136M Mar/2026
Dexcom USD 2.22B 81.3M Mar/2026
Edwards Lifesciences USD 1.41B 404.7M Mar/2026
Fujifilm JPY 1.26T 57.74B Mar/2026
Globus Medical USD 482.46M 16.04M Mar/2026
Henry Schein USD 3.3B 69M Mar/2026
Idexx Laboratories USD 1.3B 151.04M Mar/2026
Inogen USD 64.94M 2.12M Sep/2025
Insulet USD 687.5M 7.4M Mar/2026
Integra LifeSciences USD 346.85M 109.14M Mar/2026
Intuitive Surgical USD 2.51B 3.2M Mar/2026
Masimo USD 325.4M 46.2M Mar/2026
Neogen USD 150.6M 3.55M Dec/2025
Orthofix International USD 161.03M 9.45M Mar/2026
Phibro Animal Health USD 281.87M 500K Mar/2026
ResMed USD 1.35B 103.1M Mar/2026
Roche Holding CHF 28B 421M Dec/2025
Steris USD 1.14B 222.7M Mar/2026
Tandem Diabetes Care USD 247.96M 5.24M Mar/2026
Teleflex USD 728.05M 33.98M Mar/2026
Thermo Fisher Scientific USD 14.62B 568M Mar/2026
Zoetis USD 2.05B 182M Mar/2026